We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Countdown to Celanese (CE) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS
Read MoreHide Full Article
Wall Street analysts expect Celanese (CE - Free Report) to post quarterly earnings of $1.91 per share in its upcoming report, which indicates a year-over-year decline of 5%. Revenues are expected to be $2.75 billion, down 3.7% from the year-ago quarter.
Over the last 30 days, there has been an upward revision of 0.9% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
In light of this perspective, let's dive into the average estimates of certain Celanese metrics that are commonly tracked and forecasted by Wall Street analysts.
The collective assessment of analysts points to an estimated 'Net Sales- Acetyl Chain' of $1.19 billion. The estimate points to a change of -4.5% from the year-ago quarter.
Analysts forecast 'Net Sales- Engineered Materials' to reach $1.56 billion. The estimate points to a change of -4.5% from the year-ago quarter.
Analysts expect 'Operating EBITDA- Acetyl Chain' to come in at $337.65 million. Compared to the current estimate, the company reported $370 million in the same quarter of the previous year.
Analysts' assessment points toward 'Operating EBITDA- Engineered Materials' reaching $304.42 million. The estimate compares to the year-ago value of $327 million.
Over the past month, shares of Celanese have returned -4.2% versus the Zacks S&P 500 composite's -2.7% change. Currently, CE carries a Zacks Rank #3 (Hold), suggesting that its performance may align with the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Countdown to Celanese (CE) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS
Wall Street analysts expect Celanese (CE - Free Report) to post quarterly earnings of $1.91 per share in its upcoming report, which indicates a year-over-year decline of 5%. Revenues are expected to be $2.75 billion, down 3.7% from the year-ago quarter.
Over the last 30 days, there has been an upward revision of 0.9% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
In light of this perspective, let's dive into the average estimates of certain Celanese metrics that are commonly tracked and forecasted by Wall Street analysts.
The collective assessment of analysts points to an estimated 'Net Sales- Acetyl Chain' of $1.19 billion. The estimate points to a change of -4.5% from the year-ago quarter.
Analysts forecast 'Net Sales- Engineered Materials' to reach $1.56 billion. The estimate points to a change of -4.5% from the year-ago quarter.
Analysts expect 'Operating EBITDA- Acetyl Chain' to come in at $337.65 million. Compared to the current estimate, the company reported $370 million in the same quarter of the previous year.
Analysts' assessment points toward 'Operating EBITDA- Engineered Materials' reaching $304.42 million. The estimate compares to the year-ago value of $327 million.
View all Key Company Metrics for Celanese here>>>
Over the past month, shares of Celanese have returned -4.2% versus the Zacks S&P 500 composite's -2.7% change. Currently, CE carries a Zacks Rank #3 (Hold), suggesting that its performance may align with the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>